• 
  Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, et al.. Impact of body mass index on overall survival in patients with metastatic breast cancer. Breast, 2021, 55, pp.16-24. ⟨10.1016/j.breast.2020.11.014⟩. ⟨hal-03345238⟩
• 
  Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
• 
  Julie Egea, Julia Salleron, Sophie Gourgou, Ahmet Ayav, Valérie Laurent, et al.. Development of a clinical-biological model to assess tumor progression in metastatic pancreatic cancer: Post hoc analysis of the PRODIGE4/ACCORD11 trial. Cancers, 2022, 14 (20), pp.5068. ⟨10.3390/cancers14205068⟩. ⟨hal-03901662⟩
• 
  Paul Retif, Sophie Deneuve, Céline Mirjolet, Thierry Bastogne, Mirlande Duclos, et al.. Proof of concept of a binary blood assay for predicting radiosensitivity. Cancers, 2021, 13 (10), pp.2477. ⟨10.3390/cancers13102477⟩. ⟨hal-03307388⟩
• 
  Clémence Basse, Antoine Italiano, Nicolas Penel, Olivier Mir, Claire Chemin, et al.. Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years. International Journal of Cancer, 2019, 145 (8), pp.2135-2143. ⟨10.1002/ijc.32307⟩. ⟨hal-02504786⟩
• 
  Garazi Ruiz de Azua, Isabelle Kousignian, Ines Vaz-Luis, Antonio Di Meglio, Elsa Caumette, et al.. Sustainable return to work among breast cancer survivors. Cancer Medicine, 2023, ⟨10.1002/cam4.6467⟩. ⟨hal-04196116⟩
• 
  Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, Guilhem Roubaud, Yohann Loriot, et al.. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study. Clinical Genitourinary Cancer, 2021, 19 (4), pp.e216-e222. ⟨10.1016/j.clgc.2021.02.005⟩. ⟨hal-03631553⟩
• 
  Pauline Marolleau, David Tougeron, Benoît Allignet, Romain Cohen, David Sefrioui, et al.. Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. International Journal of Cancer, In press, ⟨10.1002/ijc.34636⟩. ⟨hal-04155601⟩
• 
  Antonio Di Meglio, Julie Havas, Arnauld S. Gbenou, Elise Martin, Mayssam El-Mouhebb, et al.. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. Journal of Clinical Oncology, 2022, 40 (27), pp.3190--3204. ⟨10.1200/JCO.21.00277⟩. ⟨hal-03855946⟩
• 
  Marius Ilié, Julien Mazières, Emmanuel Chamorey, Simon Heeke, Jonathan Benzaquen, et al.. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC. Journal of Thoracic Oncology, 2021, 16 (5), pp.807-816. ⟨10.1016/j.jtho.2021.01.1617⟩. ⟨hal-03663313⟩
• 
  Florence Duffaud, Antoine Italiano, Emannuelle Bompas, Maria Rios, Nicolas Penel, et al.. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩. ⟨hal-03623638⟩
• 
  Véronique Vendrely, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Angélique Saint, et al.. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE. Radiotherapy & Oncology, 2023, 183, pp.109542. ⟨10.1016/j.radonc.2023.109542⟩. ⟨hal-04016479⟩
• 
  François Quénet, Dominique Elias, Lise Roca, Diane Goéré, Laurent Ghouti, et al.. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 2021, 22 (2), pp.256-266. ⟨10.1016/s1470-2045(20)30599-4⟩. ⟨hal-03220825⟩
• 
  J.M. Hannoun-Lévi, M.-È. Chand, P. Blanchard, C. Chargari, A. Escande, et al.. Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique. Cancer/Radiothérapie, 2020, 24, pp.876 - 881. ⟨10.1016/j.canrad.2020.03.010⟩. ⟨hal-03493632⟩
• 
  Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, et al.. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study). Gynecologic Oncology, 2020, 159, pp.256 - 263. ⟨10.1016/j.ygyno.2020.07.021⟩. ⟨hal-03491450⟩
• 
  F. Derquin, A. Floquet, A.C. Hardy-Bessard, J. Edeline, J.P. Lotz, et al.. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Gynecologic Oncology, 2020, 158 (3), pp.666-672. ⟨10.1016/j.ygyno.2020.06.491⟩. ⟨hal-02909552⟩
• 
  Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Christine Lasset, et al.. Variation in breast cancer risk with mutation position smoking alcohol and chest X-ray history in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Research and Treatment, 2011, 130 (3), pp.927-938. ⟨10.1007/s10549-011-1655-3⟩. ⟨hal-00698006⟩
• 
  L. Julien, J. Genet, N. Leymarie, J.-F. Honart, F. Rimareix, et al.. Comparaison des résultats de reconstruction mammaire immédiate par prothèse avec et sans radiothérapie. Annales de Chirurgie Plastique Esthétique, 2020, 65, pp.181 - 197. ⟨10.1016/j.anplas.2019.12.002⟩. ⟨hal-03490268⟩
• 
  Guillaume Janoray, Yoann Pointreau, Marc Alfonsi, Christian Sire, Lionel Geoffrois, et al.. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer, 2020, 133, pp.86 - 93. ⟨10.1016/j.ejca.2020.04.009⟩. ⟨hal-03490774⟩
• 
  Jérôme Durand-Labrunie, Anne-Sophie Baumann, Ahmet Ayav, Valérie Laurent, Emmanuel Boleslawski, et al.. Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial. International Journal of Radiation Oncology, Biology, Physics, 2020, 107, pp.116 - 125. ⟨10.1016/j.ijrobp.2019.12.004⟩. ⟨hal-03490661⟩

105

191